Mostrando 7 resultados de: 7
Filtros aplicados
Subtipo de publicación
Article(7)
Publisher
Basic and Clinical Pharmacology and Toxicology(2)
Journal of Pharmaceutical Health Services Research(2)
PLoS ONE(1)
Pharmacoepidemiology and Drug Safety(1)
Revista Panamericana de Salud Publica/Pan American Journal of Public Health(1)
Anticholinergic Exposure in a Cohort of Adults Aged 80 years and Over: Associations of the MARANTE Scale with Mortality and Hospitalization
ArticleAbstract: Anticholinergics are frequently prescribed for older adults and can lead to adverse drug events. ThePalabras claves:Autores:Azermai M., Carlos E. Durán, Christiaens T., Dalleur O., Degryse J., Elseviers M., Klamer T., Vaes B., Vander Stichele R., Wauters M.Fuentes:scopusA Novel Scale Linking Potency and Dosage to Estimate Anticholinergic Exposure in Older Adults: the Muscarinic Acetylcholinergic Receptor ANTagonist Exposure Scale
ArticleAbstract: Quantification of the anticholinergic exposure insufficiently or imprecisely incorporates dosage infPalabras claves:Autores:Azermai M., Carlos E. Durán, Christiaens T., Elseviers M., Klamer T., Vander Stichele R., Wauters M.Fuentes:scopusData sources for drug utilization research in Latin American countries—A cross-national study: DASDUR-LATAM study
ArticleAbstract: Purpose: Drug utilization research (DUR) contributes to inform policymaking and to strengthen healthPalabras claves:cross-national, drug utilization research, Latin America, pharmacoepidemiologyAutores:Acosta A., Baldoni A.O., Barberato-Filho S., Beltrán M.M., Cañás M., Castro-Pastrana L.I., Chandia F.V., da Costa Lima E., de Cássia Bergamaschi C., de França Fonteles M.M., de Souza L.J.C., Delgado E.N., Doubova S.V., Dreser A., Elseviers M., Ferre F., Fulone I., Galvão T.F., Gómez-Galicia D.L., Hernández P.G., Herrera-Comoglio R., Leal L.F., Lopes L.C., Luiza V.L., María Belén Mena, Marin G.H., Medero N., Mónica Tarapués, Mota D.M., Olmos I., Osorio-De-Castro C.G.S., Rodríguez-Tanta Y., Roldán-Saelzer J., Salas M., Sánchez-Salgado J.C., Santa-Ana-Tellez Y., Sepúlveda-Viveros D., Silva M.T., Urtasun M.A., Zimmermann I.R.Fuentes:scopusSharp rise in the expenditures of targeted drugs in Ecuador: five-year (2010–2014) consumption of oncologic drugs in public and private hospitals
ArticleAbstract: Objective: In Ecuador, a new constitutional mandate (2008) allowed the government to implement freePalabras claves:Cáncer, drug utilization, ECUADOR, health expenditures, Latin America, molecular targeted therapy, oncologic drugsAutores:Carlos E. Durán, Christiaens T., Elseviers M., Rottey S., Vander Stichele R.Fuentes:scopusRegulatory reliance to approve new medicinal products in Latin American and Caribbean countries
ArticleAbstract: Objective. To describe the current status of regulatory reliance in Latin America and the CaribbeanPalabras claves:Caribbean Region, Drug approval, Government Agencies, Latin America, Pan american health organization, Pharmaceutical preparations, United States Food and Drug AdministrationAutores:Andia T., Cañás M., Carlos E. Durán, Christiaens T., Elseviers M., Stichele R.V., Urtasun M.A.Fuentes:scopusPolicies influencing access to new targeted oncologic drugs in Ecuadorian hospitals: an interrupted time series analysis
ArticleAbstract: Objective and methods: An interrupted time series analysis was performed to measure the impact of twPalabras claves:antineoplastic drugs, drug and therapeutic committees, drug policies, ECUADOR, interrupted time series analysis, molecular targeted therapyAutores:Carlos E. Durán, Christiaens T., Elseviers M., Patricia Granja, Rottey S., Vander Stichele R.Fuentes:scopusPotential negative impact of reputed regulators decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis
ArticleAbstract: Background Many new cancer drugs are being approved by reputed regulatory authorities without evidenPalabras claves:Autores:Cañás M., Carlos E. Durán, Christiaens T., Elseviers M., Stichele R.V., Urtasun M.A.Fuentes:scopus